Nephrology & urology
Kidney & urinary clinical trials
Kidney disease and conditions of the bladder and urinary tract. We’re tracking 4,387 recruiting studies in this area right now.
By phase
- Not applicable2,710
- Phase 2569
- Phase 1367
- Phase 3266
- Phase 1/Phase 2227
- Phase 4192
- Phase 2/Phase 356
Top conditions
- Prostate Cancer645
- Bladder Cancer186
- Acute Kidney Injury133
- Chronic Kidney Diseases123
- Chronic Kidney Disease107
- Breast Cancer105
- Renal Cell Carcinoma80
- Urinary Incontinence60
- Kidney Cancer59
- Colorectal Cancer58
- Ovarian Cancer57
- Lung Cancer51
- Cancer48
- Lupus Nephritis48
- Melanoma48
- Metastatic Prostate Cancer47
- Head and Neck Cancer46
- Prostate Cancer (Adenocarcinoma)45
Leading sponsors
- Mayo Clinic64
- National Cancer Institute (NCI)48
- Peking University First Hospital39
- M.D. Anderson Cancer Center36
- Novartis Pharmaceuticals34
- Chinese University of Hong Kong33
- AstraZeneca29
- IRCCS Azienda Ospedaliero-Universitaria di Bologna29
- Memorial Sloan Kettering Cancer Center29
- Assistance Publique - Hôpitaux de Paris27
Where studies are running
- California359
- Arizona109
- Alabama107
- Florida95
- New York95
- Maryland91
- Texas91
- Massachusetts89
- Illinois66
- Minnesota50
Recruiting studies4,387 total
- NCT07798778RecruitingEarly Phase 1
New drug for advanced prostate cancer that has stopped responding to hormone therapy
This trial tests a new drug called SRT-017 for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The drug targets a marker on cancer cells (PSMA) and may help slow the disease. The study will check if it is safe and effective.
Wuxi, JiangsuAges 18 years+ - NCT05874674Recruiting
Testing nafamostat to reduce bleeding risk during dialysis
This pilot study tests whether nafamostat is safe for people on hemodialysis who have a high risk of bleeding. It may help clinicians find safer ways to manage blood clotting medicines during dialysis.
Wŏnju, KangwondoAges 18–99 - NCT06524726Recruiting
PNH registry for people with confirmed PNH
This is a long-term registry study for people with a confirmed diagnosis of paroxysmal nocturnal hemoglobinuria (PNH). It simply collects information over time to better understand the condition and how it's managed. There is no experimental treatment involved.
Altamonte Springs, FloridaAges Any age - NCT04110821Recruiting
Quality of life after prolapse treatment, surgery or non-surgery
This study looks at how people’s quality of life changes after treatment for pelvic organ prolapse, comparing conservative (non-surgical) and surgical options. It may help doctors understand which approach leads to better day-to-day well-being for similar patients.
BaselAges 18 years+ - NCT06529549Recruiting
Organoid drug test for advanced prostate cancer
This trial uses a lab test on a tiny sample of your tumor (called an organoid) to find which drug might work best for your advanced prostate cancer. It's for men whose cancer has stopped responding to hormone therapy and got worse after first treatment.
Guangzhou, GuangdongAges 18–75 - NCT06530004Recruiting
Rituximab for childhood nephrotic syndrome: a follow-up study
This study follows children with nephrotic syndrome (a kidney condition causing swelling) who are being treated for the first time with rituximab. It aims to see how well the medication works long-term.
Xiamen, FujianAges 1–18 - NCT07789041Recruiting
PuraStat gel for less bleeding after aquablation surgery
This study tests whether a special gel called PuraStat can reduce bleeding after aquablation surgery for prostate problems, which might allow patients to go home the same day. If you're having this surgery, the gel may help you recover faster and leave the hospital sooner.
Glenview, IllinoisAges 18 years+ - NCT07784465Recruiting
Biofeedback and pelvic floor training after hysterectomy
This study tests whether adding biofeedback to pelvic floor muscle training improves sexual function and quality of life after hysterectomy. Biofeedback is a technique that uses sensors to help you better control your pelvic muscles.
Kafr ash Shaykh, KafrelsheikhAges 45–50 - NCT07786844RecruitingPhase 1/Phase 2
Norepinephrine irrigation fluid for kidney stone surgery
This study tests whether adding norepinephrine (a medicine that helps narrow blood vessels) to the fluid used during kidney stone surgery can reduce bleeding. It is for people with stones in the kidney or upper ureter who are having a specific minimally invasive surgery.
Nanjing, JiangsuAges 18–75 - NCT07788625Recruiting
Focal therapy for prostate cancer not visible on MRI
This study tests a new way to treat prostate cancer that is not visible on MRI but is detected by a special PET scan. The treatment is a focal therapy that targets only the cancer while sparing healthy tissue, and it aims to control the cancer with fewer side effects.
Hong Kong, 香港島Ages 50 years+ - NCT07790718Recruiting
Exercise program to prevent colorectal cancer after prostate radiation
This study tests whether an exercise program can help prevent colorectal cancer in men who have had pelvic radiation for prostate cancer. It involves using an iPhone app to track activity and attending exercise sessions.
Duarte, CaliforniaAges 40–80 - NCT06537037Recruiting
Imaging study of urologic cancer with radiogenomics
This study looks at how scans (CT or MRI) can help doctors understand the environment around urologic tumors. It may lead to better ways to predict treatment response and outcomes.
Wuhan, HubeiAges 18 years+ - NCT07784387Recruiting
Bladder cancer study in Portugal
This study looks at the characteristics and outcomes of people with high-risk non-muscle-invasive bladder cancer in Portugal. It aims to understand the disease better and could help improve future treatments.
LisbonAges 18 years+ - NCT07788014RecruitingPhase 1
Testing a new medicine for healthy adults
This study tests a new investigational drug called GV-100 to see how safe it is and how the body handles it. It is for healthy adults and will be given in different doses to find the best one.
Adelaide, South AustraliaAges 18–65 - NCT07792408RecruitingPhase 1
Study of VX-407 and oral contraceptive interaction
This study tests how a new drug, VX-407, affects the levels of a combined oral contraceptive in your body. Participants must be healthy adults aged 18 to 65 with a certain body weight and BMI.
MontrealAges 18–50 - NCT07792317Recruiting
Cold storage treatment for donated kidneys before transplant
This study tests a special cold storage solution and machine to keep donated kidneys healthy before they are transplanted. It may help the kidneys work better after surgery.
RotterdamAges 18 years+ - NCT05360914Recruiting
Hospital care at home for older adults with acute illnesses
This trial tests whether it is safe and helpful to manage certain sudden (acute) infections and medical problems with hospital-level care delivered at home or in a nursing home. It may help you avoid unnecessary hospital stays while still getting close medical follow-up.
SilkeborgAges 65 years+ - NCT06544720RecruitingPhase 1
SCG142 TCR-T cell therapy for HPV-related cancers
This trial tests a new treatment called SCG142 TCR-T cells for cancers caused by HPV. The therapy uses your own immune cells to fight the tumor. It may help if other treatments haven't worked or are not available.
Qingdao, ShandongAges 18 years+ - NCT07781124Recruiting
Remote monitoring for kidney dialysis patients
This study compares the effectiveness and resource use of remote patient monitoring across different dialysis methods for people with end-stage renal disease. It aims to see if remote monitoring can improve care and outcomes.
Beijing, Beijing MunicipalityAges 18–79 - NCT07783802RecruitingPhase 2
Study of clazakizumab for adults with high inflammation and heart risk
This study tests whether clazakizumab can reduce the risk of heart attacks or strokes in people with high levels of inflammation (measured by a blood test called hsCRP) and conditions like heart disease, obesity, diabetes, high blood pressure, or kidney disease. If you qualify, you'll receive either the study drug or a placebo to see if it helps lower your risk.
Huntsville, AlabamaAges 18 years+ - NCT07776626RecruitingPhase 1
Study of YOLT-203 for Primary Hyperoxaluria Type 1
This study tests a new treatment for primary hyperoxaluria type 1, a rare condition that causes too much oxalate in the body, which can lead to kidney stones and kidney damage. The treatment is given as an injection, and the study will see if it is safe and how the body responds.
Shanghai, Shanghai MunicipalityAges 6 years+ - NCT06550479Recruiting
Comparing three types of arm fistulas for dialysis
This trial compares three types of surgical connections (fistulas) between an artery and a vein in the arm, used for dialysis. It looks at which type works best for people with advanced kidney disease who need a new access point for dialysis.
WroclawAges 18 years+ - NCT06343038RecruitingPhase 1
A new targeted radiation drug for advanced prostate cancer
This trial tests a new radioactive drug (161Tb-SibuDAB) for men with metastatic prostate cancer that has grown despite standard treatments. It aims to find the right dose and see if it can shrink tumors.
BaselAges 18 years+ - NCT07782164Recruiting
Irreversible electroporation for recurrent pelvic tumors
This study tests a new technique called irreversible electroporation (IRE) for treating pelvic tumors that have returned despite earlier treatment. IRE uses electrical pulses to destroy cancer cells without surgery, offering a potential option when other local treatments like surgery or radiation are not suitable.
Amsterdam, North HollandAges 18 years+
Common questions
- How many kidney & urinary clinical trials are recruiting?
- Clin2 is tracking 4,387 recruiting nephrology & urology studies from the U.S. registry right now, out of 6,805 we cover in this area in total.
- What does “Kidney & urinary” cover here?
- Kidney disease and conditions of the bladder and urinary tract. We group each study into kidney & urinary based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a kidney & urinary trial near me?
- Use the search to filter kidney & urinary studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.